UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063715
Receipt number R000072906
Scientific Title A Randomized Controlled Trial Evaluating the Efficacy of Electrical Muscle Stimulation as an Exercise Alternative for Female Office Workers
Date of disclosure of the study information 2026/11/20
Last modified on 2026/11/20 22:33:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study of the Effects of Electrical Muscle Stimulation on Muscle Strength in Female University Employees

Acronym

Female Employee EMS Study

Scientific Title

A Randomized Controlled Trial Evaluating the Efficacy of Electrical Muscle Stimulation as an Exercise Alternative for Female Office Workers

Scientific Title:Acronym

Female Office Worker EMS RCT

Region

Japan


Condition

Condition

Healthy adult women without regular exercise habits

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether electrical muscle stimulation (EMS) performed in a seated position during working hours improves lower limb muscle strength (knee extension strength) compared with a control group maintaining their usual daily activities among female employees without regular exercise habits, using a randomized controlled trial. The study also aims to assess the effects of EMS on physical function, physical activity, muscle mass, quality of life, and work functioning.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in knee extension muscle strength from baseline to 12 weeks after the start of the intervention, measured using a handheld dynamometer.

Key secondary outcomes

1. Physical function: Changes from baseline to weeks 4, 8, 12, and 16 in Short Physical Performance Battery (SPPB) measures, including balance, walking, and chair stand tests, and handgrip strength.
2. Body composition: Changes from baseline to weeks 4, 8, 12, and 16 in muscle mass, fat mass, and extracellular water ratio measured using bioelectrical impedance analysis (InBody).
3. Physical activity and sedentary time: Changes from baseline to week 12 in daily sedentary time, ambulatory activity time (walking and running), and non-ambulatory activity time measured using an accelerometer-based activity monitor.
4. Work functioning: Changes from baseline to weeks 4, 8, 12, and 16 in Work Functioning Impairment Scale (WFun) scores.
5. Health-related quality of life: Changes from baseline to weeks 4, 8, 12, and 16 in Health-Related Quality of Life-4 (HRQOL-4) scores.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

EMS intervention group: Participants will receive electrical muscle stimulation (EMS) using a belt-electrode EMS device (PULSE Trainer, Homer Ion Laboratory Co., Ltd.) in a seated position during working hours. Stimulation will be delivered at frequencies of 4 Hz and 20 Hz for 9 minutes and 30 seconds each, for approximately 20 minutes per session, three times per week for 12 weeks. Stimulation intensity will be adjusted to the maximum tolerable level during working hours. EMS will be discontinued after the 12-week intervention period, followed by a 4-week follow-up period.

Interventions/Control_2

Control group: Participants will continue their usual working and daily activities without receiving EMS intervention. No additional exercise guidance or specific intervention will be provided during the 12-week observation period. Physical function, body composition, physical activity, work functioning, and health-related quality of life will be assessed according to the same schedule as the EMS intervention group. After the 12-week observation period, participants will continue their usual daily activities and undergo a 4-week follow-up period.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Female

Key inclusion criteria

Participants must meet all of the following inclusion criteria:

1. Female employees working at the Yoshida, Tokiwa, or Kogushi campus of Yamaguchi University, excluding healthcare professionals working at Yamaguchi University Hospital.
2. Individuals who have not regularly engaged in exercise for at least 30 minutes per session, at least twice per week, for one year or longer.
3. Aged 20 to 69 years at the time of informed consent.
4. Able to undergo EMS during working hours, with permission from their department head.
5. Able to understand the study procedures and provide voluntary written informed consent after receiving sufficient information about the study.

Key exclusion criteria

Employees meeting any of the following criteria will be excluded from the study:

1 Individuals with implanted electrical devices including cardiac pacemakers
2 Individuals with a current or previous history of malignancy
3 Pregnant or breastfeeding women
4 Individuals with untreated hypertension
5 Individuals with heart disease
6 Individuals with vascular disease
7 Individuals with renal dysfunction or suspected renal dysfunction
8 Individuals with infectious or inflammatory diseases
9 Individuals with diabetes mellitus
10 Individuals who have been advised by a physician to remain at rest
11 Individuals with epilepsy
12 Individuals with diagnosed or suspected thrombosis
13 Individuals with suspected undernutrition defined as BMI less than 18.5 kg per m2
14 Individuals with neurological or muscular disorders
15 Individuals with psychiatric disorders
16 Individuals with difficulty walking
17 Individuals with skin abnormalities at the EMS application site
18 Healthcare professionals working at Yamaguchi University Hospital
19 The principal investigator or co investigators of this study
20 Individuals considered unsuitable for study participation by the principal investigator or a co investigator at the Health Science Center

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Noriko
Middle name
Last name Fukue

Organization

Yamaguchi University

Division name

Wellness Science Center

Zip code

753-8511

Address

Yoshida 1677-1, Yamaguchi, Yamaguchi

TEL

0839335160

Email

nfukue@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Noriko
Middle name
Last name Fukue

Organization

Yamaguchi University

Division name

Wellness Science Center

Zip code

753-8511

Address

Yoshida 1677-1, Yamaguchi, Yamaguchi

TEL

0839335160

Homepage URL


Email

nfukue@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi University Hospital Research Ethics Committee

Address

Minami-Kogushi 1-1-1, Ube, Yamaguchi

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 07 Day

Date of IRB

2026 Year 11 Month 11 Day

Anticipated trial start date

2026 Year 12 Month 15 Day

Last follow-up date

2031 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 20 Day

Last modified on

2026 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072906